Literature DB >> 29997997

A surgical case of lung cancer with poor general status associated with parathyroid hormone-related protein.

Toshiko Kamata1, Eitetsu Koh1, Atsuko Masunaga2, Asako Okabayashi3, Mizue Hasegawa3, Hideki Katsura3, Kenzo Hiroshima2, Yasuo Sekine1.   

Abstract

Parathyroid hormone-related protein (PTHrP), which is released in the presence of malignant disease, is associated with hypercalcemia. Complete resection of the tumor in such patients is rarely performed because of their poor general condition. We herein report a case of lung cancer associated with PTHrP in a patient whose condition dramatically improved after surgery. We also review the literature on the benefits of various surgical options. Although only a few cases of complete resection in such patients have been reported, the mental and physical condition of the patients improved postoperatively and the median survival time was longer than 12 months. A poor general status is frequently considered a contraindication for surgery, even in a palliative setting; however, we conclude that resection of lung cancer may lead to improved symptom control and survival when the patient's condition is induced by hypercalcemia secondary to PTHrP secretion from the tumor.

Entities:  

Keywords:  Lung cancer; humoral hypercalcemia of malignancy (HHM); parathyroid hormone-related protein (PTHrP); surgery

Year:  2018        PMID: 29997997      PMCID: PMC6006080          DOI: 10.21037/jtd.2018.04.96

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  13 in total

1.  BRONCHOGENIC CARCINOMA SIMULATING HYPERPARATHYROIDISM.

Authors:  D M TAYLOR; A W SIEMSEN
Journal:  Arch Intern Med       Date:  1965-01

2.  Bronchial carcinoma with hypercalcaemia simulating cerebral metastases.

Authors:  N J Strickland; A M Bold; W E Medd
Journal:  Br Med J       Date:  1967-09-02

Review 3.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Native and a synthetic analogue of the malignancy-associated parathyroid hormone-like protein have in vitro transforming growth factor-like properties.

Authors:  K L Insogna; A F Stewart; C A Morris; L M Hough; L M Milstone; M Centrella
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

5.  A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer.

Authors:  Thomas J Miner; Murray F Brennan; David P Jaques
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

6.  A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression.

Authors:  L J Suva; G A Winslow; R E Wettenhall; R G Hammonds; J M Moseley; H Diefenbach-Jagger; C P Rodda; B E Kemp; H Rodriguez; E Y Chen
Journal:  Science       Date:  1987-08-21       Impact factor: 47.728

7.  Hypercalcemia induced by parathyroid hormone-related protein from lung cancer tissue.

Authors:  H Tanaka; S Kobayashi; A Masaoka; S Honda; K Yamaguchi
Journal:  Chest       Date:  1991-11       Impact factor: 9.410

8.  Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma.

Authors:  E Takai; T Yano; H Iguchi; Y Fukuyama; H Yokoyama; H Asoh; Y Ichinose
Journal:  Cancer       Date:  1996-10-01       Impact factor: 6.860

Review 9.  Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.

Authors:  Aibek E Mirrakhimov
Journal:  N Am J Med Sci       Date:  2015-11

10.  A case of squamous cell lung carcinoma with high concentration of parathyroid hormone-related peptide in serum and pleural effusion presenting hypercalcemia.

Authors:  H Iguchi; H Katakami; Y Ichinose; Y Nishi; S Tanaka; N Hara; M Ohta; M Haji; H Nawata
Journal:  Jpn J Cancer Res       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.